<?xml version="1.0" encoding="UTF-8"?>
<fig id="f0015">
 <label>Fig. 3</label>
 <caption>
  <p>Comparison of the efficacy of favipiravir and oseltamivir in lethal influenza virus infection. Mice were infected with 3 × 10
   <sup>4</sup> plaque forming units of influenza A/PR/8/34 virus and were orally administered favipiravir and oseltamivir at doses of 200 and 400 mg/kg/day for 5 days beginning at 1 h post-infection (
   <italic>n</italic> = 14). The results presented in this figure were obtained from a representative experiment. *
   <italic>P</italic> &lt; .01 compared to 0.5% methylcellulose solution-treated controls and oseltamivir-treated groups (log-rank test). The authors obtained permission from the Antiviral Chemistry and Chemotherapy to reuse this figure (
   <xref rid="bb0560" ref-type="bibr">Takahashi et al., 2003</xref>).
  </p>
 </caption>
 <alt-text id="al0015">Fig. 3</alt-text>
 <graphic xlink:href="gr3_lrg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
